Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Shiley INFUSAID Pump technology.

J Johnston1, S Reich, A Bailey

  • 1Shiley INFUSAID, Inc., Norwood, Massachusetts 02062.

Annals of the New York Academy of Sciences
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chewing analysis of horses consuming bermudagrass hay in different styles of slow feeders as compared to loose hay.

Journal of equine veterinary science·2024
Same author

Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study.

ESMO open·2021
Same author

Staff and participant perceptions of optimal recruitment and retention strategies for biomedical cohort studies in the Caribbean.

Cancer causes & control : CCC·2021
Same author

Objective and subjective rapid frailty screening tools in people with HIV.

HIV medicine·2020
Same author

Oxytocin reduces post-stress sweet snack intake in women without attenuating salivary cortisol.

Physiology & behavior·2019
Same author

Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.

Nature communications·2019
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles

Totally implantable drug delivery devices offer safe and effective drug administration. Future applications may include advanced programmable pumps and biofeedback systems for chronic diseases.

Area of Science:

  • Biomedical Engineering
  • Pharmacology
  • Medical Devices

Background:

  • Totally implantable drug delivery devices are established as safe and effective for systemic and regional drug administration.
  • Current applications focus on continuous infusions, with ongoing development in programmable pumps for variable flow rates.

Purpose of the Study:

  • To review the benefits and future potential of totally implantable drug delivery devices.
  • To explore advancements in drug delivery technology for improved patient outcomes.

Main Methods:

  • Literature review of existing studies and technological advancements in implantable drug delivery systems.
  • Analysis of potential benefits and future applications based on current research trends.

Main Results:

Related Experiment Videos

  • These devices enhance drug efficacy while minimizing systemic toxicity.
  • They enable controlled and individualized drug dosing, improving patient quality of life.
  • Potential exists for delivering complex molecules like proteins and peptides.

Conclusions:

  • Totally implantable drug delivery devices provide significant advantages in drug therapy.
  • Future developments may lead to biofeedback-controlled closed-loop systems for managing chronic conditions such as diabetes, cardiovascular diseases, and central nervous system disorders.